ASML Beyond Chips: EUV Lithography Opens the Path to Mass Nanopores for Medicine
IMEC shows how ASML’s EUV lithography can enable industrial-scale production of nanopores for genomics, diagnostics, and personalized medicine.
BioNTech is more than just a company. It’s a symbol of Europe’s scientific courage.
The founders of BioNTech, Uğur Şahin and Özlem Türeci, have been awarded the Deutscher Nationalpreis 2025, one of Germany’s most
BIO+ Longevica: Germany Becomes a Laboratory for Healthy Longevity
By Vlad Kostiuk, Special Correspondent for FUTURUMSeptember 14, 2025, Germany If one were to sum up the current state of
Nucleus Embryo: An Innovative Technology for Future Generations
Nucleus Genomics launches Nucleus Embryo — IVF embryo screening for 900 diseases and traits, sparking debate over ethics and genetic…
Code of LongevityThe Evolution of Luxury: From Million-Dollar Watches to Longevity Biomarkers
Franc Smidt, Editor-in-Chief of FUTURUMAugust 14, 2025, Germany For centuries, wealth has been measured and expressed through objects of luxury.
🧬 AI Against Cancer: Tempus, AstraZeneca, and Pathos Build a Next-Gen Oncology Platform
Tempus, AstraZeneca, and Pathos partner to build an AI oncology platform combining genomic, clinical, and imaging data to transform cancer…
🔬 Latent Labs Raises $50M to Develop “Programmable Biology”
Latent Labs Raises $50M to Develop "Programmable Biology"The startup Latent Labs, founded by a former DeepMind employee